Watertown, Mass., January 6, 2014 – Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat cancer, announced today that it has appointed pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback